Trodelvy 180 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9JW1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,901
Award facts
- Contract value 100% obligated
- $17,901.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,901.20 delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with an ultimate completion date of January 28, 2026. This non-set-aside, firm fixed-price contract reflects a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of its parent company, Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider serving federal government agencies. Trodelvy is a specialized oncology medication, consistent with the company's extensive portfolio of brand-name and generic drugs, specialty medications, and medical supplies distributed across multiple therapeutic domains to support military treatment facilities, the Defense Health Agency, the U.S. Coast Guard, and other federal medical institutions. The non-competitive nature of this delivery order—issued under an existing indefinite delivery contract rather than through a separate solicitation—streamlines procurement for this critical pharmaceutical commodity within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9JW1?
SPE2DR26F9JW1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JW1 worth?
The government has obligated $17,901 on SPE2DR26F9JW1.
Is contract SPE2DR26F9JW1 an order under another contract?
Yes. SPE2DR26F9JW1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JW1 competed?
The extent of competition for SPE2DR26F9JW1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award